Covid-19 vaccine hopes and the bitter reality

Loading player...
There have been some promising early trials of various nascent Covid-19 vaccines, and many are hoping for a usable shot by year-end. In reality, however, we are in the very early days yet and promising early-stage trials are no guarantee of success. What’s more, the rollout of any Covid-19 vaccine promises to be a contentious political process, with the US and China staking out aggressive positions on who will have early access. In this episode, featuring content from the Bloomberg P&L podcast, we explore these issues and why we should be moderating our vaccine hopes. Bottom line: It looks like we need to learn to live with Covid-19, rather than pinning our hopes on a quick-fix vaccine solution. Learn more about your ad choices. Visit megaphone.fm/adchoices
24 May 2020 7AM English South Africa Investing · Business News

Other recent episodes

BN Daybreak Thurs 15 Jan: Abedian on SA Silence about “21st Century Nazis”; Mining Indaba's back story; Sasol Surges

In this morning's briefing, Alec Hogg unpacks a volatile geopolitical landscape where conflicting reports emerge from Iran—Donald Trump claims de-escalation while internal memos suggest mass casualties. We speak to Iranian-born and bred entrepreneur and former UCT Economics Prof Iraj Abedian, who delivers a scathing critique of the South African government's…
14 Jan 11PM 17 min

BN Briefing: Leaked Iran death toll, US-SA relations, and Equities vs Gold

In this BizNews Briefing, Dr. Iraj Abedian reveals leaked reports of 12,000 deaths in Iran, questioning the South African government’s silence. The Hudson Institute's Josh Meservey analyses Pretoria’s alignment with American adversaries. Plus, David Shapiro discusses the "survival mode" of South African business, and Peter Major explains why equities historically…
14 Jan 5AM 13 min